SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christian S. Hendershot, Eric D. Claus, Vijay A. Ramchandani, Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults, Addiction Biology, 2016, 21, 1
  2. 2
    Natalie S. McGuier, William C. Griffin, Justin T. Gass, Audrey E. Padula, Elissa J. Chesler, Patrick J. Mulholland, Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption, Addiction Biology, 2016, 21, 1
  3. 3
    Lara A. Ray, Spencer Bujarski, Daniel J. O. Roche, Subjective Response to Alcohol as a Research Domain Criterion, Alcoholism: Clinical and Experimental Research, 2016, 40, 1
  4. 4
    Michelle A. Patriquin, Isabelle E. Bauer, Jair C. Soares, David P. Graham, David A. Nielsen, Addiction pharmacogenetics, Psychiatric Genetics, 2015, 25, 5, 181

    CrossRef

  5. 5
    Audrey E Padula, William C Griffin, Marcelo F Lopez, Sudarat Nimitvilai, Reginald Cannady, Natalie S McGuier, Elissa J Chesler, Michael F Miles, Robert W Williams, Patrick K Randall, John J Woodward, Howard C Becker, Patrick J Mulholland, KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction, Neuropsychopharmacology, 2015, 40, 8, 1928

    CrossRef

  6. 6
    Sarah G. Helton, Falk W. Lohoff, Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders, Psychiatry Research, 2015, 230, 2, 121

    CrossRef

  7. 7
    A. Thompson, L. Owens, S.P. Pushpakom, M. Faizal, M. Pirmohamed, Pharmacotherapy for alcohol dependence: A stratified approach, Pharmacology & Therapeutics, 2015,

    CrossRef

  8. 8
    Daniel JO Roche, Lara A Ray, Subjective response as a consideration in the pharmacogenetics of alcoholism treatment, Pharmacogenomics, 2015, 16, 7, 721

    CrossRef

  9. 9
    Michael Soyka, Jochen Mutschler, Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015,

    CrossRef

  10. 10
    James C. Garbutt, Amy M. Greenblatt, Suzanne L. West, Laura C. Morgan, Alexei Kampov-Polevoy, Harmon S. Jordan, Georgiy V. Bobashev, Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence, Addiction, 2014, 109, 8
  11. 11
    Mary-Anne Enoch, Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism, Pharmacology Biochemistry and Behavior, 2014, 123, 17

    CrossRef

  12. 12
    L. A. Ray, S. Bujarski, L. M. Squeglia, J. R. Ashenhurst, R. F. Anton, Interactive Effects of OPRM1 and DAT1 Genetic Variation on Subjective Responses to Alcohol, Alcohol and Alcoholism, 2014, 49, 3, 261

    CrossRef

  13. 13
    Michael Soyka, Nalmefene for the treatment of alcohol dependence: a current update, The International Journal of Neuropsychopharmacology, 2014, 17, 04, 675

    CrossRef

  14. 14
    Richard C. Crist, Wade H. Berrettini, Pharmacogenetics of OPRM1, Pharmacology Biochemistry and Behavior, 2014, 123, 25

    CrossRef

  15. 15
    Raymond F. Anton, Joseph P. Schacht, Sarah W. Book, Alcohol and the Nervous System, 2014,

    CrossRef

  16. You have free access to this content16
    Gary K. Hulse, Improving clinical outcomes for naltrexone as a management of problem alcohol use, British Journal of Clinical Pharmacology, 2013, 76, 5
  17. 17
    A. Thorsell, The  -Opioid Receptor and Treatment Response to Naltrexone, Alcohol and Alcoholism, 2013, 48, 4, 402

    CrossRef

  18. 18
    Hisham Ziauddeen, Pradeep J. Nathan, Chris Dodds, Kay Maltby, Sam R. Miller, Dawn Waterworth, Kijoung Song, Liling Warren, Louise Hosking, Mauro Zucchetto, Mark Bush, Lakshmi Vasist Johnson, Bhopinder Sarai, Karin Mogg, Brendan P. Bradley, Duncan B. Richards, Paul C. Fletcher, Edward T. Bullmore, The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects, The Journal of Clinical Pharmacology, 2013, 53, 10